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Background: Kishk is a popular traditional functional food in Egypt. This study was performed to
investigate the effects of different levels of kishk as a dried fermented milk/whole wheat mixture on
growth performance, relative weight of organs, lipid proﬁle, and some biochemical parameters in rats fed
a cholesterol-rich diet.
Methods: Forty male rats were assigned to ﬁve groups, each consisting of eight rats. The ﬁrst one pre-
sents the negative control group that received the basal diet, while the second group that serves as the
positive (þ) control group received a high-cholesterol diet (HCD). The last three groups received HCD
supplemented with 10%, 20%, and 30% of kishk.
Results: Rats fed diets containing various levels of kishk for 8 weeks had signiﬁcantly (p < 0.05) lower
body weights compared with the rats of both negative and positive groups. The liver/body weight ratio
signiﬁcantly increased in rats fed HCD compared with the control rats. Incorporation of kishk into the
HCD at levels of 10%, 20%, and 30% signiﬁcantly (p  0.05) decreased the change of liver/body weight
ratio by 14.46%, 17.51%, and 18.78%, respectively, when compared with the HCD group. Results also
indicate that rats fed HCD had a state of dyslipidemia, compared with the negative control group.
Administration of HCD supplemented with various levels of kishk for 8 weeks signiﬁcantly (p < 0.05)
attenuated the increases in serum cholesterol, low-density lipoprotein cholesterol, triglyceride concen-
tration, and atherogenic indices, and increased high-density lipoprotein cholesterol in a dose-dependent
manner compared with the HCD group. Activities of liver enzymes (alanine transferase and aspartate
transferase) as well as kidney function parameters (urea, uric acid, and creatinine) were elevated in the
HCD group compared with the negative control group.
Conclusion: Consumption of HCD supplemented with various levels of kishk for 8 weeks induced a
signiﬁcant protective effect reﬂected in the reductions of the serum levels of aspartate transferase and
alanine transferase, as well as kidney functions (uric acid, urea, and creatinine).
© 2016 Korea Food Research Institute. Published by Elsevier B.V. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Hypercholesterolemia is the presence of high levels of choles-
terol in the blood [1]. It is a form of “hyperlipidemia” (elevated
levels of lipids in the blood) and “hyperlipoproteinemia” (elevated
levels of lipoproteins in the blood) [1]. Hypercholesterolemia has
emerged as a strong risk factor for cardiovascular disease (CVD).istry, Faculty of Agriculture,
blished by Elsevier B.V. This is anCVD is a severe problem in developed and developing countries.
The World Health Organization (WHO) estimated that 17.3 million
people died from CVD in 2008 and warned that 23.6 million people
will die annually from CVD by 2030. CVD is a disease mainly caused
by atherosclerosis [2]. One of the risk factors of atherosclerosis is
hypercholesterolemia [3,4], and low-density lipoprotein choles-
terol (LDL-C) is the major cause of onset of the atherogenic process
[2]. Total cholesterol (TC) can be broken down into a diagnostic
lipoprotein proﬁle, including high-density lipoprotein (HDL), LDL,
intermediate-density lipoproteins, very-low-density lipoprotein,
chylomicron remnants, and triglycerides (TG). Patients at an
increased risk of coronary artery disease frequently exhibit anopen access article under the CC BY-NC-ND license (http://creativecommons.org/
Table 1
Proximate composition and calorie content of kishk.
Component Kishk
% Energy (kcal/100 g)
Moisture 8.97 d
Protein 18.64 74.56
Ash 7.30 d
Crude ﬁber 7.57 d
Fat 5.19 46.71
Total carbohydrate* 61.30 245.2
Total energy 366.47
* By difference.
J Ethn Foods 2016; 3: 117e123118atherogenic lipoprotein phenotype characterized by elevated
plasma levels of both TG-rich lipoproteins and small, dense LDL and
low concentrations of HDL-C. Recently, in a large observational
study, the calculated non-HDL plasma cholesterol concentration
(the sum of the cholesterol contents of LDL, intermediate-density
lipoprotein, and very-low-density lipoprotein) was a stronger
predictor of cardiovascular events than plasma cholesterol alone
[5,6]. Improvement in the predictability of coronary artery disease
on inclusion of very-low- and intermediate-density lipoprotein
cholesterol emphasizes the proatherogenic nature of TG-rich lipo-
proteins and their remnant particles. Control of cholesterol levels
through therapeutic drugs have signiﬁcantly reduced the risk of
developing atherosclerosis and associated CVDs [7e10]. Notably,
statins, a class of cholesterol-lowering drugs inhibiting cholesterol
synthesis, have most widely been prescribed for treating hyper-
cholesterolemia and reducing CVDs [8,10]. However, adverse effects
associated with therapeutic drugs, such as myopathy, liver dam-
ages, and potential drugedrug interaction, have been reported
[11e16]. Therefore, development of additional therapies for con-
trolling cholesterol levels is warranted, especially for those with
better safety proﬁles. Functional foods have played an important
role in the food industry during the past decade. These foods pro-
vide basic nutrition as well as health beneﬁts such as disease pre-
vention, or may delay the evolution of chronic disorders.
Components in these foods can produce physiological beneﬁts or
remove compounds that may pose a health risk [17]. Recent re-
searches have focused on the search for functional foods for
combating chronic diseases such as cancer, CVDs, and Type 2 dia-
betes [18]. Fermented foods are an important part of diet in many
parts of the world and are known from ancient times. Traditional
dried fermented milk/cereal foods are widely used in the diet of
people in the Middle East, Asia, Africa, and some parts of Europe
[19]. Kishk is one of the traditional food products in Egypt. It is a
fermented milkewheat mixture stored in the form of dried balls in
Egypt [20]. Kishk is a balanced food with excellent preservation
quality, richer in B vitamins than either wheat or milk, and well
adapted to hot climates by its content of lactic acid, and it has a
therapeutic value [20e22]. Kishk product is a highly nutritious food,
having a protein content of about 25.3%. It is highly digestible and of
high biological value [23]. The main objective of the present study
was to evaluate the hypocholesterolemic effect of diets containing
different levels of kishk as a dried fermented milk/cereal mixture in
rats.
2. Materials and methods
2.1. Ethics statement
This study was carried out in strict accordance with the rec-
ommendations of the Guide for the Care and Use of Laboratory
Animals published by the US National Institute of Health (NIH
Publication No. 85e23, revised 1996). Experimental design and
animal handling procedures were approved by the ethical com-
mittee of the Food Technology Research Institute, Agricultural
Research Center, Giza, Egypt. Every effort was made to minimize
the number of animals and their suffering.
Kishk was purchased from the local market in Giza, Egypt. Kishk
was ground in an electric grinder (Braun Model 1021), passed
through a 150 mmmesh sieve, and stored in glass containers at 4C
for further use. The chemical composition and energy of kishk as
determined by the Standard Association of Ofﬁcial Analytical
Chemists (AOAC) methods (2000) are shown in Table 1. Cholesterol
and cholic acid were purchased from Sigma Chemical Co., Ltd (St
Louis, MO, USA). The kits of total cholesterol (TC), high-density li-
poprotein cholesterol (HDL-C), low-density lipoprotein cholesterol(LDL-C), Triglyceride (TG), transaminase enzymes [aspartate
transferase (AST) and alanine transferase (ALT)], and kidney func-
tion parameters (creatinine, urea, and uric acid) were obtained
from Biodiagnostic Co. (Dokki, Giza, Egypt). All chemicals used
were of analytical reagent grade.2.2. Animals and experiment design
Forty male Albino rats with an average weight of 190e200 g
were obtained from experimental animals of the Food Technology
Research Institute, Agricultural Research Center, Giza, Egypt. The
animals were pair housed in plastic cages at 25 ± 2C and a hu-
midity of 55± 6% with a 12-hour lightedark cycle. Food and water
were provided ad libitum throughout the study. All the rats were
acclimated to the basal diet for 2 weeks to stabilize the metabolic
conditions before carrying out feeding experiments. The basal diet
was formulated according to the AOACmethods [24], and consisted
of casein (15%), corn oil (10%), cellulose (5%), salt mixture (4%),
vitamin mixture (1%), and starch (65%). Casein is characterized by
its low content of sulfur-containing amino acids; hence, L methio-
nine was added to the basal diet at the level of 4.6 g/kg diet. The
composition of the vitamin and salt mixtures used was similar to
that reported by AOAC [24] and Reeves et al [25], respectively. The
rats were randomly divided into ﬁve groups (n ¼ 8). The ﬁrst one
presents the negative control group, which was fed only the basal
diet, while the second group, which serves as the positive (þ)
control group, was fed a high-cholesterol diet (HCD) containing
98.75% basal diet, 1% cholesterol, and 0.25% cholic acid. The third,
fourth, and ﬁfth groups were fed HCD supplemented with 10%, 20%,
and 30% of kishk respectively. The animal experiments conducted
according to the recommendations of the Guide for the Care and
Use of Laboratory Animals, published by the US National Institute of
Health (NIH Publication No. 85e23, revised 1996). Experimental
design and animal handling procedures were approved by the
ethical committee of the Food Technology Research Institute;
Agricultural Research Center, Giza, Egypt. Every effort was made to
minimize the number of animals and their suffering.2.3. Biological evaluation
Daily food intake and weekly body weights were recorded
during the experimental period (8 weeks). At the end of the
experiment, total food intake, body weight gain, and food efﬁciency
ratio were calculated.2.4. Relative organ weight (g) of experimental rats
At the time of sacriﬁce, the hearts, livers, and kidneys of the
experimental rats were identiﬁed, removed, rinsed with physio-
logical saline solution, and dried by tissue papers. Weights of
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recorded.
2.5. Blood sampling
At the end of experimental period (8 weeks), rats were sacriﬁced
after an overnight fast. The blood of each rat group was collected,
centrifuged (3,500 rpm, 10 minutes, 4C) to obtain the sera, and
kept in a deep freezer (e25C) until analysis.
2.6. Biochemical analyses
TC, HDL-C, LDL-C, and TG were determined according to the
methods of Roeschlau et al [26], Assmann [27], Levy [28], and
Fossati and Prencipe [29], respectively.
2.7. Atherogenic indices
The atherogenic index (AI) and the cardiac risk factor were
calculated using the following formulas: AI ¼ TC e HDL-C/HDL-C
[30], and cardiac risk factor ¼ TC/HDL-C [31]. Activities of alanine
aminotransferase (ALT) (E.C. 2.6.1.2) and aspartate aminotrans-
ferase (AST) (E.C. 2.6.1.1) were measured according to the methods
described by Bergmeyer and Harder [32]. Urea, uric acid, and
creatinine levels in rat serawere determined as outlined by Fawcett
and Scott [33], Barham and Trinder [34], and Bartles et al [35],
respectively.
2.8. Statistical analysis
Data are expressed as mean ± standard deviation. Data were
statistically analyzed in completely randomized design in factorial
arrangement according to the procedures outlined by Gomez and
Gomez [36], and the treatment means were compared by least
signiﬁcant differences and Duncan multiple range using Excel
(Microsoft Ofﬁce 2007) and SPSS Version 18.0 (SPSS Inc., Chicago,
IL, USA). Data are presented in text and tables as the means of ﬁve
determinations.
3. Results and discussion
Table 2 shows initial and ﬁnal body weights, body weight gain,
and feed intake of the rats. The weight gain and food intake of the
rats fed the HCD were signiﬁcantly higher than the rest of the
groups (Table 2). Rats fed a diet rich in cholesterol are often used as
an experimental model for dietary hyperlipidemia; these ratsTable 2
Body weight gain and average food intake of experimental rats.
Groups Initial body
weight (g)
Final body
weight (g)
Weight
gain (g)
Average food
intake (g/d)
Control 195.5a± 18.1 264.7a± 19.5 69.2b ± 4.61 13.9a± 0.90
HCD 187.9a± 14.3 271.6a± 21.2 83.7 a ± 6.20 16.6a± 1.45
DK10 179.7a± 17.6 242.5a± 17.3 62.8b,c ± 5.70 14.7a± 1.30
DK20 198.1a± 16.2 258.2a± 21.4 60.1b,c ± 4.21 14.9a± 1.62
DK30 190.1a± 13.4 244.5a± 14.8 54.4c ± 7.33 15.1a± 1.25
LSD at 0.05 29.65 34.57 10.41 2.41
Data are expressed as mean ± SD.
Values given represent means of ﬁve determinations.
Values followed by the same letter are not signiﬁcantly different (p < 0.05).
Control represents rats fed the basal diet HCD.
DK10, high-cholesterol diet supplemented with 10% of kishk; DK20, high-
cholesterol diet supplemented with 20% of kishk; DK30, high-cholesterol diet sup-
plemented with 30% of kishk; HCD, high-cholesterol diet; SD, standard deviation.
Least signiﬁcant difference at p  .05 according to Duncan's multiple-range test.exhibit increased plasma TG, TC, and LDL-C; decreased circulation
of HDL-C; and an overweight state [37]. Addition of kishk to the
HCD caused signiﬁcant (p < 0.05) reductions in body weight gain.
This reduction increased gradually and signiﬁcantlywith increasing
levels of kishk incorporated in the diet. This ﬁnding suggests that
daily consumption of dried fermented milk/wheat mixture is
effective in reducing weight gain. Several works have reported that
the reduction in weight gain is associated with the consumption of
ﬁber-rich foods, particularly whole-grain products, as part of a
healthy lifestyle [38,39]. Dietary ﬁber may exhibit its impacts on
food intake and body weight gain through different mechanisms.
The satiating effect elicited by both soluble dietary ﬁber and
insoluble dietary ﬁber is not only a consequence of mechanical
intestinal distension by the bulking action of nondigested and un-
absorbed food components and water; delayed starch digestion
and glucose absorption also reduce glycemic and insulin responses,
prolonging satiety and reducing energy consumption [40]. Dietary
ﬁber can also affect food intake by modulating the production of
gut hormones involved in appetite regulation such as ghrelin (an
orexigenic peptide) or anorexigenic hormones such as glucagon-
like peptide-1, peptide YY, or the adipocyte-produced leptin;
these hormones would also affect lipid metabolism and energy
expenditure, thus inﬂuencing body weight [41,42]. The total feed
intake was similar in all groups throughout the experimental
period. There were no statistically signiﬁcant differences (p > 0.05)
between control diet, HCD diet, and HCD diet supplemented with
different levels of kishk. This ﬁnding indicates that addition of kishk
into the diet did not affect the approximate feed intake in all groups
(Table 2).3.1. Relative organ weight (g) of experimental rats
Weighing of organs of treated animals may reveal speciﬁc organ
changes related to the treatment [43]. There were no signiﬁcant
differences in the heart and kidney/body weight ratios in all groups
under study. On the contrary, the liver/body weight ratio signiﬁ-
cantly increased in rats fed a cholesterol-rich diet (HCD) compared
with the control rats. These increases could be attributed to the
accumulation of cholesterol in the liver [44]. The highest change in
the liver/body weight ratio was observed for rats receiving an HCD
(Table 3). This ﬁnding is similar to those reported by Jemai et al [42]
and Osfor et al [45], who found that the liver/body weight ratio
increased in rats fed a cholesterol-rich diet compared with those
fed the control diet. Incorporation of kishk into the HCD diet at
levels of 10%, 20%, and 30% could signiﬁcantly (p  0.05) decrease
the change of liver/body weight ratio by 14.46%, 17.51%, and 18.78%,
respectively, when compared with the liver/body weight ratio of
the HCD group. Higher dietary ﬁber content may have increasedTable 3
Relative weight (%) of organs of experimental rats.
Groups Liver Kidney Heart
Control 3.16b ± 0.45 0.71a± 0.12 0.30a± 0.02
HCD 3.94a± 0.06 0.86a± 0.09 0.33a± 0.01
DK10 3.37b ± 0.29 0.72a± 0.10 0.31a± 0.03
DK20 3.25b ± 0.18 0.76a± 0.03 0.33a± 0.02
DK30 3.20b ± 0.21 0.70a± 0.08 0.30a± 0.01
LSD at 0.05 0.366 0.124 0.037
Data are expressed as mean ± SD.
Values given represent means of ﬁve determinations.
Values followed by the same letter are not signiﬁcantly different (p < 0.05).
Control represents rats fed the basal diet HCD.
DK10, high-cholesterol diet supplemented with 10% of kishk; DK20, high-
cholesterol diet supplemented with 20% of kishk; DK30, high-cholesterol diet sup-
plemented with 30% of kishk; HCD, high-cholesterol diet; SD, standard deviation.
Least signiﬁcant difference at p  .05 according to Duncan's multiple-range test.
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ings revealed that high-ﬁber diets and probiotic bacteria of dairy
products may have synergistic effects and reduce the accumulation
of cholesterol in the liver.3.2. Effect of tested diets on lipid proﬁle
Total cholesterol, LDL-C, HDL-C, triacylglycerol concentrations
(mg/dL), and AIs of rats fed HCD and HCD supplemented with
different levels of kishk are presented in Table 4. Generally, the ﬁnal
values of serum cholesterol and LDL-C of rats fed either HCD or HCD
supplemented with different levels of kishk were signiﬁcantly
(p  0.05) higher than those of rats fed the negative control diet
(NCD). Numerous studies showed that the increased levels of TC
and LDL-C raise the risk of developing atherosclerosis and coronary
heart disease [47e49]. Consumption of the cholesterol-rich diet
resulted in signiﬁcant (p  0.05) increases of TC, with values
approximately 2.59 times higher than those in NCD rats (Table 4).
However, when kishk was incorporated into the HCD, signiﬁcant
reductions of 17.22%, 19.23%, and 26.06% in the TC levels were
observed in comparison with the HCD group that consumed cel-
lulose as a source of ﬁber. There were signiﬁcant (p  0.05) differ-
ences in LDL-C values between rats fed NCD and experimental
groups. Rats fed HCD had the highest (126 ± 3.92 mg/dL) concen-
tration of LDL-C (p  0.05). Inclusion of different levels of kishk into
the HCD caused a signiﬁcant (p 0.05) decline in the concentration
of LDL-C. The concentration of LDL-C of rats fed diets supplemented
with 10%, 20%, and 30% of kishkwere, respectively, about 1.23, 1.46,
and 1.87 times as low as those of rats fed the HCD. Wheat ﬁber
reduced serum cholesterol level by increasing the surface area for
bile binding or altering the quantity of short-chain fatty acids [50].
Several studies have shown that propionate generated from dietary
ﬁbers containing polysaccharides exhibits hypocholesterolemic
effects and offsets acetate generation, which tends to increase
serum cholesterol via a mechanism probably involving liver lipo-
genesis [51e54]. The reduction of cholesterol is possibly a sum of
several effects; the most accepted one is decreased absorption of
bile acids that causes removal of steroids from the body by fecal
excretion, resulting in increased catabolism of cholesterol, an in-
crease in the secretion of bile acids, a decrease in lipoprotein
cholesterol secretion, and a reduction in the total body pool of
cholesterol [55].
In this regard, kishk is typically prepared by adding strained
yoghurt to parboiled wheat and allowing the mix to ferment at an
ambient temperature for different periods of time [20e22]. From
this viewpoint, probiotic lactobacilli play a vital role in lowering
cholesterol levels [56,57]. During anaerobic growth, Lactobacillus
acidophilus removed cholesterol from the laboratory mediaTable 4
TC, LDL-C, HDL-C, and TG concentrations (mg/dL); atherogenic index; and cardiac risk fa
Parameters Control HCD D
TC 90.28d ± 2.59 234a ± 6.31 193.7b
LDL 43.3e ± 1.21 156a ± 3.92 112b
HDL 41.14a ± 1.32 26.6d ± 0.96 32.25c
TG 71.01b ± 4.84 97.67a ± 4.99 81.60b
AI 1.19e ± 0.01 7.79a ± 0.08 5.00b
Cardiac risk factor 2.19e ± 0.01 8.92a ± 0.08 6.76b
Data are expressed as mean ± SD. Values given represent means of ﬁve determinations.
Values followed by the same letter are not signiﬁcantly different (p < 0.05).
Control represents rats fed the basal diet HCD.
AI, atherogenic index; DK10, high-cholesterol diet supplemented with 10% of kishk; DK20
supplemented with 30% of kishk; HCD, high-cholesterol diet; HDL, high-density lipoprote
low-density lipoprotein cholesterol; SD, standard deviation; TC, serum total cholesterol;
Least signiﬁcant difference at p  .05 according to Duncan's multiple-range test.supplemented with cholesterol and bile salts [58]. Several studies
showed that L. acidophilus or related lactobacilli controlled serum
cholesterol levels [59e62]. L. acidophilus interferes with the
enterohepatic circulation of bile acids, which in itself could be an
important factor in reducing serum cholesterol levels. L. acidophilus
can deconjugate bile acids [63]. Bile, a water-soluble end product of
cholesterol in the liver, is stored and concentrated in the gall-
bladder and released into the duodenum upon ingestion of food
[64]. It consists of cholesterol, phospholipids, conjugated bile acids,
bile pigments, and electrolytes. Once deconjugated, bile acids are
less soluble and absorbed by the intestines, leading to their elimi-
nation in the feces. Cholesterol is used to synthesize new bile acids
in a homeostatic response, resulting in lowering of serum choles-
terol [64]. The hypocholesterolemic effect of the probiotics has also
been attributed to their ability to bind cholesterol in the small in-
testines [65]. Compared with the NCD group, there were signiﬁcant
(p  0.05) reductions in the concentration of HDL-C in HCD groups.
HDL-C decreased signiﬁcantly from 41.14 mg/dL in rats fed NCD to
26.6 mg/dL in rats fed HCD. Moreover, the concentration of HDL-C
of rats fed HCD supplemented with various levels of kishk increased
signiﬁcantly (p < 0.05) compared with those of rats in the HCD
group. Indeed, signiﬁcant increases (21.24%, 35.33%, and 50.97%) in
the level of HDL-C were observed for rats fed on HCD containing
10%, 20%, and 30% of kishk, respectively, in comparison with the
HCD group. These increases in HDL-C levels of rats fed HCD sup-
plemented with various levels of kishkmay be due to the reduction
in TC considering that dietary ﬁber increases the enzymatic activity
of cholesterol-7 alpha-hydroxylase, the key regulatory enzyme in
the hepatic conversion of cholesterol to bile acids, thereby
contributing to higher depletion of hepatic cholesterol [66]. Several
studies have demonstrated that high levels of HDL-C are associated
with a lower incidence of CVDs due to the inhibition of LDL
oxidation and protection of endothelial cells from the cytotoxic
effects of oxidized LDL [67,68]. The increased HDL facilitates the
transport of cholesterol from the serum to the liver, where it is
catabolized and excreted from the body.
Addition of different levels of kishk into the HCD was able to
attenuate both TC and LDL-C, and elevate the level of HDL-C in
serum of rats.
Rats fed HCD had signiﬁcantly higher TG values compared with
those fed NCD. Addition of different levels of kishk into the HCD
caused signiﬁcant (p 0.05) reductions in TG levels. TG level in rats
fed HCD was 97.67 mg/dL, which is 16.45%, 16.86%, and 25.01%
higher than in rats fed HCD supplemented with 10%, 20%, and 30%
of kishk, respectively (Table 4). These reductions in TG levels may be
due to the formation of a protective layer by the dietary ﬁber
around the cholesterol-containing lipid drops, which prohibits
absorption in the intestine [69,70]. Dietary ﬁbers increase thector in rats fed experimental diets for 8 weeks.
K10 DK20 DK30 LSD at 0.05
± 14.09 189bc ± 11.0 173c ± 6.9 16.55
± 12.9 86.1c ± 7.0 67.3d ± 2.9 12.62
± 1.34 36.0b ± 1.52 40.16a ± 0.98 2.26
± 5.12 81.22b ± 4.16 73.24b ± 5.26 8.89
± 0.18 4.25c ± 0.08 3.31d ± 0.07 0.18
± 0.18 5.38c ± 0.08 4.31d ± 0.07 0.18
, high-cholesterol diet supplemented with 20% of kishk; DK30, high-cholesterol diet
in; HDL-C, high-density lipoprotein cholesterol; LDL, low-density lipoprotein; LDL-C,
TG, triglycerides.
Table 5
Effect of HCD and HCD supplemented with different levels of kishk on some liver and kidney functions.
Group Liver functions Kidney functions
Aspartate aminotransferase (AST) (IU/L) Alanine aminotransferase (ALT) (IU/L) Urea (mg/dL) Creatinine (mg/dL) Uric acid (mg/dL)
Control 36.50d ± 1.60 24.60d ± 0.73 26.60b ± 4.10 0.66b ± 0.09 1.94b ± 0.19
HCD 49.40a ± 4.02 36.06a ± 1.19 34.20a ± 1.60 1.40a ± 0.13 2.60a ± 0.23
DK10 45.30b ± 1.20 33.20b ± 1.35 31.40ab ± 1.20 0.78b ± 0.10 2.10b ± 0.16
DK20 41.70bc ± 0.96 29.10c ± 1.89 29.00b ± 0.96 0.73b ± 0.09 1.98b ± 0.18
DK30 38.10cd ± 2.00 25.42d ± 1.36 27.10b ± 1.10 0.71b ± 0.11 1.96b ± 0.17
LSD at 0.05% 4.07 2.47 3.89 0.19 0.34
Data are expressed as mean ± SD. Values given represent means of ﬁve determinations.
Values followed by the same letter are not signiﬁcantly different (p < 0.05).
Control represents rats fed the basal diet HCD.
ALT, alanine transferase; AST, aspartate transferase; DK10, high-cholesterol diet supplemented with 10% of kishk; DK20, high-cholesterol diet supplemented with 20% of kishk;
DK30, high-cholesterol diet supplemented with 30% of kishk; HCD, high-cholesterol diet; SD, standard deviation.
Least signiﬁcant difference at p  .05 according to Duncan's multiple-range test.
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which may alter the efﬁciency of droplet disruption and coales-
cence in the stomach and small intestine [17]. This ﬁnding complies
with the ﬁndings that ﬁbers of fruits cereals and vegetables
reduced the levels of triacylglycerols in rodents [70e72]. AI is
considered to be an important parameter of atherosclerosis. AI in-
dicates the risk of deposition of foam cells, plaque, and fatty inﬁl-
tration or lipids in the heart, coronaries, aorta, liver, and kidney
[73]. The abovementioned data reﬂected in the values of AI and
the cardiac risk factor. Generally, the values of AI and the cardiac
risk factor of rats fed either HCD or HCD supplemented with
different levels of kishkwere signiﬁcantly (p  0.05) higher than in
rats fed the NCD. The highest value of AI (7.79) was recorded for rats
fed HCD. Administration of different levels of dried kishk led to a
signiﬁcant (p < 0.05) reduction in the AI value. AI values of rats fed
HCD supplemented with 10%, 20%, and 30% of kishk were, respec-
tively, about 1.55, 1.83, and 2.36 times as low as those of rats fed
HCD.
The same trend was observed for cardiac risk factor (Table 4).
Hypercholesterol is a risk factor for CVD, which is a leading cause of
death inmany countries [74]. A 1% reduction in serum cholesterol is
estimated to result in 2e3% reduction in the risk of coronary artery
disease [75]. It is suggested that intestinal lactobacilli may reduce
serum cholesterol level through bacterial assimilation in the in-
testine [58] and deconjugation of bile salts [76,77]. Short-chain
fatty acids produced by lactobacilli may also inhibit hepatic
cholesterol synthesis and distribution of cholesterol in the plasma
and liver [78]. Numerous studies showed that the increased levels
of TC and LDL-C raise the risk of developing atherosclerosis and
coronary heart disease [47e49]. On the contrary, a raised level of
HDL-C was associated with a reduced risk of atherosclerosis, since
HDL in serum is thought to facilitate the translocation of excess
cholesterol from the peripheral tissue to the liver for further
catabolism [79].
3.3. Effect of tested diets on some liver and kidney functions
Table 5 summarizes the effect of HCD and HCD supplemented
with different levels of kishk on some liver and kidney functions.
Assessment of the levels of AST and ALT provides a good and simple
tool to measure the protective activity of the target drug against the
hepatic damage of the target compounds [80]. ALT and AST enzyme
activities of rats fed HCD and HCD supplemented with different
levels of kishk for 8 weeks compared with those of the rats of the
NCD group are presented in Table 5. Rats fed with HCD for 8 weeks
had signiﬁcant increases in the activities of AST and ALT enzymes
(35.34% and 46.58%, respectively; p < 0.05) compared with the NCD
group. Consumption of HCD induces damage to the rat liver due tooxidative stress caused by the excess of cholesterol in the diet. This
oxidative stress damages cells due to an increase in free radicals
and consequent lipid peroxidation [81e83]. However, administra-
tion of various levels of kishk reversed the injuries induced by HCD
to normal values (Table 5). No signiﬁcant (p  0.05) differences in
the activities of serum ALT and AST were shown for rats adminis-
trated HCD incorporating 30% of kishk and for the control group.
These ﬁndings are consistent with another result suggesting a
protective role of dietary ﬁbers [84,85]. The mean values of creat-
inine, urea, and uric acid in rats fed HCD were signiﬁcantly higher
than those in rats of the NC group (Table 5). Hypercholesterolemia
is considered a factor that contributes to renal dysfunction [86]. The
hypercholesterolemia leads to reduced renal blood ﬂow and
increased renal vascular resistance [87], which are factors directly
related to the impairment of renal function. Signiﬁcant (p  0.05)
reductions were seen in the levels of creatinine, urea, and uric acid
for rats fed HCD supplemented with various levels of kishk. In the
same time, no signiﬁcant (p  0.05) changes in the levels of
creatinine, urea, and uric acid were shown for rats administrated
HCD supplemented with various levels of kishk and for the control
group. Such ﬁndings coincided with those of El Rabey et al [85],
who showed that dietary ﬁber signiﬁcantly improves the level of
kidney function.Conﬂicts of interest
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